Search ATPC
Agape ATP Corp
Nasdaq · CIK 1713210
Last close2.06
Daily change+0.04 (2.03%)
10 Years gain-99.98%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
ATPC · STANDARD
SIC 8000 · Services-Health Services · Fiscal year end 1231
Fundamental
39.3Momentum
0.0Acceleration
37.5Confidence
82.0Annual Revenue9
Quarterly Revenue33
Annual CFO10
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.0 / 25
Quality5.3 / 25
Capital Efficiency4.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics10.0 / 10
Forward Indicators5.0 / 5
Signals
ROIC expansionROIC improved by 8.7291 percentage points.
Warnings
Operating margin compression · MEDIUMOperating margin compressed by 84.6277 percentage points.
Heavy share dilution · HIGHDiluted share count increased 420.0191%.
Key Metrics
Revenue Growth TTM-33.11%OK
Revenue CAGR 3Y-6.36%OK
Gross Margin54.99%OK
Operating Margin-283.38%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-8.52%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y420.02%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $1.52M | $838,270.00 | -$3.26M | -$2.41M | n/a | 55% | -213.65% | n/a | -23.17% | 801,081 |
| 2025 FY Dec 31, 2024 | $1.32M | $759,148.00 | -$2.57M | -$2.73M | n/a | 57.39% | -194.55% | n/a | n/a | 77,839 |
| 2024 FY Dec 31, 2023 | $1.43M | $936,572.00 | -$2.15M | -$2.00M | n/a | 65.44% | -150% | n/a | n/a | 3.79M |
| 2023 FY Dec 31, 2022 | $1.86M | $1.19M | -$1.53M | -$811,683.00 | n/a | 64.13% | -82.59% | n/a | -295.93% | 87.82M |
| 2022 FY Dec 31, 2021 | $1.02M | $719,629.00 | -$1.86M | -$845,842.00 | n/a | 70.76% | -182.76% | n/a | -94.05% | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $864,973.00 | sum latest 4 fiscal quarters Revenue | OK | 0001493152-26-037992, 0001493152-25-022092 |
| Revenue Growth TTM | -33.11% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001493152-26-037992, 0001493152-25-022092 |
| Revenue CAGR 3Y | -6.36% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001493152-26-016297 |
| Revenue CAGR 5Y | -15% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001493152-26-016297 |
| Gross Profit CAGR 3Y | -11.04% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001493152-26-016297 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001493152-26-037992, 0001493152-25-022092 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 54.99% | Gross Profit / Revenue | OK | 0001493152-26-037992, 0001493152-25-022092 |
| Operating Margin | -283.38% | Operating Income / Revenue | OK | 0001493152-26-037992, 0001493152-25-022092 |
| ROIC | -8.52% | NOPAT / Average Invested Capital | OK | 0001493152-26-037992, 0001493152-25-022092 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001493152-26-037992 |
| Current Ratio | 8.45x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $0.86 | Revenue / Diluted Shares | OK | 0001493152-26-037992, 0001493152-25-022092 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |